Related Experiment Video
Updated: Jun 18, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention.
Mattia Galli1,2, Renzo Laborante1, Felicita Andreotti1,3
1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Reviews in Cardiovascular Medicine
|July 30, 2024
Summary
Percutaneous coronary intervention (PCI) increases bleeding risk, necessitating strategies to mitigate this complication. Research focuses on new devices, techniques, and medications to reduce bleeding in PCI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
- While generally safe, PCI is associated with significant short- and long-term bleeding risks.
- Bleeding complications following PCI are linked to adverse patient outcomes.
Purpose of the Study:
- To review the mechanisms and prevalence of bleeding in patients undergoing PCI.
- To discuss current evidence and practical approaches to managing bleeding risk.
- To explore future strategies for preventing and treating bleeding complications.
Main Methods:
- Literature review of studies on bleeding in PCI patients.
- Analysis of current antithrombotic therapies and their impact on bleeding.
- Discussion of novel PCI devices and techniques aimed at reducing bleeding.
Main Results:
- PCI patients face persistent bleeding risks due to necessary antithrombotic therapy.
- Bleeding is a significant predictor of poor outcomes in this population.
- Ongoing research is exploring various methods to minimize bleeding events.
Conclusions:
- Reducing bleeding is a critical goal in PCI management.
- A multi-faceted approach involving optimized antithrombotic strategies and innovative techniques is essential.
- Further research is needed to refine bleeding prevention and treatment protocols.
Related Concept Videos
01:24Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.8K
01:05Introduction to Hemostasis
6.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.9K